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ObituaryProfessor Donald Metcalf (1929–2014)Donald Metcalf was one of the world’s
leading experimental hematologists. His
discoveries in the fields of colony stimu-
lating factors, cell signaling, and blood
cell development not only established
many of the concepts of modern hema-
tology but also led to revolutions in
the treatment of patients undergoing
chemotherapy and bone-marrow trans-
plants, treatments that have benefitted
millions of patients worldwide. Much of
his scientific work was at the Walter
and Eliza Hall Institute in Melbourne dur-
ing the time it was a hotbed of research
on the adaptive immune system. How-
ever, he stood apart in insisting on the
importance of what we now term the
innate immune system and waited for
immunologists to catch up, as they
now have. Although the last thing he
would have wanted is to be termed an
immunologist, he nevertheless made
major contributions to the field. Almost
forgotten but crucial at the time was
his early work on the biology of the
thymus, an organ whose function had
yet to be properly defined. He continued
as a collaborator with immunologists,
bringing his insights and laboratory skills
to problems of immune system develop-
ment, which, for him, was just another
branch of hematology.
Donald Metcalf (Don, to us) was born
in the small country town of Mittagong
in New South Wales, Australia. He was
the middle child of three (sisters Beryl
and Rosalind), and both of his parents
were schoolteachers. His father, Donald
Davidson Metcalf, was the son of
a Scottish migrant and no doubt
ingrained in his son the virtues of hard
work and discipline. Don was constantly
on the move as his parents took up
posts at various country schools be-
tween the times of the Great Depres-
sion and World War II. Don was a bright
and conscientious student and he ob-
tained a scholarship to study medicine
at the University of Sydney. During his
degree, Don worked in the laboratory
of Professor Patrick de Burgh on the
ectromelia virus and this experience
had a profound effect on him, commit-
ting him to a life of medical research.
He graduated in 1953 as a Bachelorof Medicine and Surgery and, during
his medical residency at the Royal
Prince Alfred Hospital, he met a
beautiful young nurse, Josephine Len-
taigne, who would become his wife
and life-long partner. They would raise
four daughters, Katherine, Mary-Ann,
Penelope, and Johanna.
In 1954, Don was offered the inau-
gural Carden Fellowship of the then
Anti-Cancer Council of Victoria to work
at the Walter and Eliza Hall Institute of
Medical Research. This fellowship pro-
vided Don with a salary and some
money for research. Extraordinarily,
Don held this fellowship continuously
until his death. The eminent virologist
Sir Macfarlane Burnet was Director of
the Institute at that time, but he had
rather fixed ideas on areas of research
and had little time for those who
thought that cancer was a disease
that could be cured. Accordingly Don
was banished to crude laboratories
above the animal house. The terms of
the Carden Fellowship were to ‘‘find
the cause and cure of cancer’’ and in
honoring this commitment Don turned
to an investigation of the role of the
thymus in lymphoid leukemia develop-
ment. From 1956 to 1958, Don under-Immunitytook a postdoctoral fellowship at Har-
vard University with Jacob Furth,
whose ideas regarding cancer develop-
ment as ‘‘an imbalance of cell regula-
tors’’ would significantly influence
Don’s thinking.
Don returned to the Walter and Eliza
Hall Institute and initially continued his
work on the thymus, an organ that very
few people were interested in at the
time. One notable exception was Jac-
ques Miller who would become a close
colleague and friend at the Institute.
One has only to read through Don’s
1966 monograph ‘‘The Thymus: Its
Role in Immune Responses, Leukaemia
Development and Carcinogenesis’’ to
realize the remarkable aptitude he
possessed as a researcher. Meticulous
in experimental design and execution,
he was a peerless anatomist, patholo-
gist, and cytologist. His writing was
clear and precise, notable for its separa-
tion of observation and experimental
fact from theoretical speculation. These
were the defining characteristics that
Don would carry throughout his scienti-
fic career.
Don’s analysis of thymic leukemo-
genesis in the AKR mouse strain was
considered definitive. But his studies
also provided fundamental information
on the functions of the normal thymus.
He documented the effects of thymec-
tomy and thymic grafting on peripheral
lymphoid tissue and with an elegant
series of thymic grafting experiments
demonstrated the autonomous control
of lymphocyte proliferation within the
thymus. He demonstrated that lympho-
cytes populating grafted thymic tissue
were derived from the host and pro-
posed that this occurred from the then
speculative hemopoietic stem cell within
the host bone marrow. His painstaking
radioautographic analysis of thymic cell
kinetics demonstrated that the thymus
generated about one third of its cell num-
ber each day and led him to conclude
that most of these thymocytes born in
the thymus must die there. Few at the
time accepted that a biological system
could be that wasteful, so it was many
years before extensive intrathymic death
was accepted as the necessary price of42, January 20, 2015 ª2015 Elsevier Inc. 1
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T cell repertoire. Don’s scrupulous ‘‘bal-
ance sheet’’ approach to thymocyte ki-
netics formed the basis of subsequent
work on T cell development in the
thymus by Ken Shortman and Roland
Scollay at the Walter and Eliza Hall
Institute.
Don next aimed to discover the regula-
tors controlling blood cell formation, and
this theme would possess him for the
next 50 years. In 1965, Ray Bradley, a
scientific collaborator at the University of
Melbourne, walked across the road to
show Don dishes of semi-solid agar in
which were growing small cellular col-
onies from mouse bone marrow. These
were dependent on an appropriate under-
layer of tissue fragments that ‘‘condi-
tioned’’ the medium and presumably
secreted growth factors. It was this tech-
nique that allowed the growth of individual
blood cells in vitro for the first time. Both
Don and Bradley realized that the growth
of these colonies, each derived from a
single cell, required the addition of
something to the culture medium. These
were proposed as soluble ‘factors’ that
supported the survival and clonogenic
growth of myeloid bone marrow and
spleen blood cell colonies. Don and
Bradley termed these ‘‘colony-stimulating
factors’’ (CSFs). The semi-solid agar cul-
ture system had provided a robust
method for detecting and quantifying the
concentrations of the proposed but yet-
undiscovered CSFs. Much would hinge
on this astute observation, which was
also made contemporaneously by a
group headed by Leo Sachs at the
Weizmann Institute in Israel. Optimizing
this clonogenic culture system laid the
groundwork for the purification and
genetic cloning of the CSFs, a Herculean
task that would take several decades
and hundreds of collaborators. Impor-
tantly, CSFs would prove to be critical
for cells that comprise the innate immune
system by regulating their proliferation,
differentiation, effector function, and
survival.
Don’s other great insight was that
this culture system provided a method
by which he could explore the cellular
basis of blood cell production in great
detail. This was another theme to
which he was committed to for the
rest of his career. Together with James
Till and Ernest McCulloch at the2 Immunity 42, January 20, 2015 ª2015 ElsevOntario Cancer Institute, Don was a
pioneer in revealing the hematopoietic
hierarchy, beginning at what he re-
garded as the apex of progenitor cell
development, the multipotential blast
colony-forming cell.
Don Metcalf led from the front the
effort to purify and clone CSFs. Now
deputy director of the Walter and Eliza
Hall Institute under the new director, Sir
Gustav Nossal, Don formed a team
across the institute and the Melbourne
branch of the Ludwig Institute for Cancer
Research. These important collaborators
included Nick Nicola, Antony Burgess,
and Richard Stanley, who possessed
the necessary skills and expertise
outside Don’s own recognized talents,
but carried the same level of commit-
ment to the task. Purification of the
CSFs required the development of the
then emergent technologies of protein
purification by high-performance liquid
chromatography to demonstrate the ex-
istence of four principal CSFs that sup-
ported myeloid colony growth and
differentiation. This required two de-
cades of continuous work.
Ultimately, it was amino-acid
sequencing and the arrival of molecular
biology that allowed the cloning of the
murine and human genes for CSFs. It
speaks to Don’s fastidiousness that he
was only convinced a pure CSF had
been discovered when they were in
possession of the CSF’s genetic
sequence. The Parkville group obtained
extensive amino-acid sequence for mu-
rine G-CSF and GM-CSF in collaboration
with Lindsay Sparrow from the CSIRO
and Richard Simpson at the Ludwig Insti-
tute. A further collaboration between
Metcalf, Burgess, Nicola, Anne Kelso,
Nick Gough, and Ashley Dunn led to
the cloning of the murine GM-CSF
gene; the G-CSF gene being cloned by
Nagata in Japan. It was Don’s leadership
that ushered in the era of molecular
hematology, which made possible the
efficiencies of scale required for CSF
production for research and clinical
applications.
Potential benefits ever at the forefront
of his thinking and a key motivation,
Don single-mindedly sought to translate
his discoveries into benefits for patients
with blood cancers. Clinical trials and
translational research were well under-
way and defined clinical uses for CSFs,ier Inc.in particular G-CSF for supporting
neutrophil recovery, which is required to
replenish the innate immune system
following chemotherapy. During these tri-
als performed in collaboration with clini-
cians Richard Fox, Glenn Begley, and
William Sheridan, Don and Uli Du¨hrsen
first observed that stem and progenitor
cells moved into the peripheral blood
following injection of G-CSF. This single
unexpected observation led to the para-
digm shift of mobilizing stem cells into
the blood for collection, largely replacing
bone marrow as a stem cell source for
transplantation.
Although CSFs can be used as a ther-
apy to boost blood cell production, more
recently John Hamilton, Burgess, Ian
Wicks, and others, along with Don,
recognized that a ‘‘dark side’’ to their
action could occur in inflammatory dis-
ease. Here, M-CSF and GM-CSF have
been shown to be pro-inflammatory in
collagen induced arthritis through regula-
tion of macrophage- and granulocyte-
lineage cells. The pioneering work to
identify the structure of CSFs and cell
surface receptors for CSFs led by Don,
David Gearing, Gough, and Nicola de-
cades ago became instrumental in the
development of CSF antagonists that
could be used for treating diseases
such as rheumatoid arthritis. Building
on this fundamental work, programs
that have led to the development of ther-
apeutics to target both ligand and recep-
tors in inflammatory diseases have
reached phase III clinical trials.
For five decades, Don Metcalf stood at
the very center of this maelstrom of scien-
tific and clinical activity. Yet, even in his
80s, he collaborated at the bench with
the immunologists Ken Shortman, Shalin
Naik, and Priyanka Sathe in their studies
on dendritic cell development, using his
clonal colony assays to determine the he-
matopoietic potential of bone-marrow
precursor populations. As a consequence
this non-immunologist even published in
Immunity!
Don was known for his formidable work
ethic and exacting scientific observations
to the point of obsession. He remained at
the laboratory bench and beside his
beloved microscope for his entire career.
Don was brutally honest with a dry wit and
had little tolerance for work he considered
superficial. Typical were his comments on
those hoping to patent SNPs without
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they are like ‘‘blind dogs staggering
around the room, bumping into chair
legs, then pissing on them.’’ But Don
was a giving collaborator whose natural
qualities of leadership had engendered
great respect and indeed great affec-
tion from those who worked with him.
His colleagues effectively became an
extended family.Don Metcalf was a scientist with rare
insight and great foresight. We will miss
him dearly.
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